Cargando…
Red face may be a specific sign of SARS-CoV-2 alpha variant
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during treatment. Two of them suddenly worsened...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247189/ https://www.ncbi.nlm.nih.gov/pubmed/34230877 http://dx.doi.org/10.1016/j.idcr.2021.e01214 |
_version_ | 1783716469120434176 |
---|---|
author | Nakaya, Aya Ogura, Eiji Katayama, Yuki Yoshii, Masami Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Yoshioka, Mami Kawano, Yuri Arai, Yuka Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki |
author_facet | Nakaya, Aya Ogura, Eiji Katayama, Yuki Yoshii, Masami Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Yoshioka, Mami Kawano, Yuri Arai, Yuka Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki |
author_sort | Nakaya, Aya |
collection | PubMed |
description | Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during treatment. Two of them suddenly worsened shortly after. We assumed that the red face reflected a cytokine storm and conjectured that it may be a specific sign of variant type COVID-19, because we have never seen it in patients with non-variant type. Moreover, we believe that red face may be predictive of a sudden deterioration. |
format | Online Article Text |
id | pubmed-8247189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82471892021-07-02 Red face may be a specific sign of SARS-CoV-2 alpha variant Nakaya, Aya Ogura, Eiji Katayama, Yuki Yoshii, Masami Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Yoshioka, Mami Kawano, Yuri Arai, Yuka Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki IDCases Case Report Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during treatment. Two of them suddenly worsened shortly after. We assumed that the red face reflected a cytokine storm and conjectured that it may be a specific sign of variant type COVID-19, because we have never seen it in patients with non-variant type. Moreover, we believe that red face may be predictive of a sudden deterioration. Elsevier 2021-07-01 /pmc/articles/PMC8247189/ /pubmed/34230877 http://dx.doi.org/10.1016/j.idcr.2021.e01214 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Nakaya, Aya Ogura, Eiji Katayama, Yuki Yoshii, Masami Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Yoshioka, Mami Kawano, Yuri Arai, Yuka Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki Red face may be a specific sign of SARS-CoV-2 alpha variant |
title | Red face may be a specific sign of SARS-CoV-2 alpha variant |
title_full | Red face may be a specific sign of SARS-CoV-2 alpha variant |
title_fullStr | Red face may be a specific sign of SARS-CoV-2 alpha variant |
title_full_unstemmed | Red face may be a specific sign of SARS-CoV-2 alpha variant |
title_short | Red face may be a specific sign of SARS-CoV-2 alpha variant |
title_sort | red face may be a specific sign of sars-cov-2 alpha variant |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247189/ https://www.ncbi.nlm.nih.gov/pubmed/34230877 http://dx.doi.org/10.1016/j.idcr.2021.e01214 |
work_keys_str_mv | AT nakayaaya redfacemaybeaspecificsignofsarscov2alphavariant AT oguraeiji redfacemaybeaspecificsignofsarscov2alphavariant AT katayamayuki redfacemaybeaspecificsignofsarscov2alphavariant AT yoshiimasami redfacemaybeaspecificsignofsarscov2alphavariant AT yoshinoeiko redfacemaybeaspecificsignofsarscov2alphavariant AT hozumikazuya redfacemaybeaspecificsignofsarscov2alphavariant AT tagosaori redfacemaybeaspecificsignofsarscov2alphavariant AT teranishiyuko redfacemaybeaspecificsignofsarscov2alphavariant AT minamibashiyuki redfacemaybeaspecificsignofsarscov2alphavariant AT haradamakiko redfacemaybeaspecificsignofsarscov2alphavariant AT yoshiokamami redfacemaybeaspecificsignofsarscov2alphavariant AT kawanoyuri redfacemaybeaspecificsignofsarscov2alphavariant AT araiyuka redfacemaybeaspecificsignofsarscov2alphavariant AT yoshidakeno redfacemaybeaspecificsignofsarscov2alphavariant AT shimizushozo redfacemaybeaspecificsignofsarscov2alphavariant AT ogurakazuma redfacemaybeaspecificsignofsarscov2alphavariant AT iwashitakatsuaki redfacemaybeaspecificsignofsarscov2alphavariant AT redfacemaybeaspecificsignofsarscov2alphavariant |